Different Effects of the Liver Mitogens Triiodo-Thyronine and Ciprofibrate on the Development of Rat Hepatocellular Carcinoma

Abstract

Previous work has shown that treatment with thyroid hormone (T3) decreased the incidence of rat hepatocellular carcinoma (HCC). The present study was designed to determine whether the inhibitory effect of T3 on HCC development was limited to early steps of the carcinogenetic process or, whether a similar effect could also be exerted by starting T3 treatment at later stages. Hepatic nodules were induced in Fischer rats by a single dose of DENA, followed by a 2-week exposure of the animals to 2-AAF and partial hepatectomy. Rats were then divided into 3 groups: group 1 was maintained on basal diet; group 2 was fed a diet containing 4 mg/kg T3 for a week, every month/7 months, starting 9 weeks after DENA administration; group 3 was exposed to cycles of T3 starting 8 months after initiation. Results demonstrate that inhibition of HCC development was essentially similar in rats exposed to T3 starting either 9 weeks or 8 months after initiation (50% inhibition compared to control rats). We have previously shown that T3-induced nodule regression and HCC inhibition occurred in spite of its mitogenic effect. Therefore, we next wished to determine whether a similar antitumoral effect could be exerted by other liver mitogens, such as peroxisome proliferators. Rats exposed to the initiation-promotion protocol described previously, were subjected to 11 cycles of a T3 or a ciprofibrate-supplemented diet, each cycle consisting of 7 days/month; the incidence of HCC and lung metastases was determined 13.5 months after initiation. Results showed that although treatment with T3 strongly inhibited HCC development (only 31% of T3+ rats showed HCC vs 91% of controls), rats given ciprofibrate developed the same number of HCC as T3-untreated rats. In conclusion, the results of this study showed that the anticarcinogenic effect of T3 is maintained also when treatment begins late in the process, and its antitumoral property appears to be specific and may not be shared by other liver mitogens.

Keywords

Hepatocellular carcinoma thyroid hormone ciprofibrate cell proliferation hyperplastic nodules.

References

Ames BN , Gold LS ( 1990). Too many rodent carcinogens: Mitogenesis increases mutagenesis . Science 249: 970—971.

Bannasch P. (1996). Pathogenesis of hepatocellular carcinoma: Sequential cellular, molecular and metabolic changes. Prog Liver Dis 14: 161—197.

Bonkovsky HL , Ponka P. , Bacon BR , Drysdale J. , Grace ND , Tavill AS (1996). An update on iron metabolism: Summary of the Fifth International Conference on Disorders of Iron Metabolism. Hepatology 24: 718— 729.

Cai Y. , Nelson BD , Li R. , Luciakova K. , DePierrre JW (1996). Thyromimetic action of the peroxisome proliferators clofibrate, perfluorococtanic acid and acetylsalicilyc acid includes changes in mRNA levels for certain genes involved in mitochondrial biogenesis. Arch Biochem Biophys 325: 107— 112.

Campbell H. , Hanigan M. , Xu Y. , Pitot H. (1986). Application of quantitative stereology to the evaluation of phenotypically heterogeneous EAF in the rat liver. J Natl Cancer Inst 76: 751—767.

Castelein H. , Gulick T. , Declerq PE , Mannaerts GP , Moore DD , Baees MI (1994). The peroxisome proliferator activated receptor regulates malic enzyme gene expression. J Biol Chem 269: 26754—26758.

Cattley RC , Popp JA ( 1989). Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital. Cancer Res 49: 3246—3256.

Chen Z-Y. , Cheng Y-H. , White CC , Eaton DL (1994). Inhibition of cell proliferation by cyprofibrate in glutathione S-transferase P1-1-positive rat hepatic hyperplastic nodules . Cancer Res 54: 2622—2629.

Cohen SM , Ellwein LB (1990). Cell proliferation in carcinogenesis. Science 249: 1007—1011.

10.

Columbano A. , Shinozuka H. (1996). Liver regeneration versus direct hyperplasia. FASEB J 10: 1118—1128.

11.

Columbano A. , Ledda-Columbano GM , Lee G. , Rajalakshmi S. , Sarma DSR (1987). Inability of mitogen-induced liver hyperplasia to support the induction of enzyme-altered islands induced by liver carcinogens. Cancer Res 47: 5557—5559.

12.

Craddock VM (1976). Cell Proliferation and Experimental Liver Cancer . In: Liver Cell Cancer, Cameron HN , Linsell DA , Warwick GP (eds). Amsterdam, Elsevier/North Holland Biochemical Press, pp 153—201.

13.

Dombrowski F. , Bannasch P. , Pfeifer U. (1997). Hepatocellular neoplasms induced by low-number pancreatic islet transplants in srteptozotocin diabetic rats. Am J Pathol 150: 1071—1087.

14.

Dombrowski F. , Klotz L. , Hacker HJ , Li Y. , Klingmuller D. , Brix K. , Herzog V. , Bannasch P. (2000). Hyperproliferative hepatocellular alterations after intraportal transplantation of thyroid follicles. Am J Pathol 156: 99—113.

15.

Francavilla A. , Carr BI , Azzarone A. , Polimeno L. , Wang Z. , Van Diehl DH , Subbotin V. , Prelich JG , Starzl TE (1994). Hepatocyte proliferation and gene expression induced by triiodothyronine in vivo and in vitro. Hepatology 20: 1237—1241.

16.

Fringes B. , Reith A. (1982). Time course of peroxisome biogenesis during adaptation to mild hyperthyroidism in rat liver. Lab Invest 47: 19— 26.

17.

Grasl-Kraupp B. , Huber W. , Just G. , Gibson R. , Schulte-Hermann R. (1990 ). Tumor promotion by the peroxisome proliferator nafenopin involving a aspecific subtype of altered foci in rat liver. Cancer Res 50: 3701— 3708.

18.

Hoofnagle JH , Everhart J. (1997). Dose-finding study of interferon alfa-n3 in hepatitis C. Hepatology 26: 1366—1367.

19.

Kew MC (2000). Hepatocellular cancer. A century of progress. Clin Liver Dis 4: 257—268.

20.

Kliewer SA , Umesono K. , Mangelsdorf DJ , Evans RM (1992). Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature 355: 446—449.

21.

Klotz L. , Hacker HJ , Klingmuller D. , Bannasch P. , Pfeifer U. , Dombrowski F. (2000). Hepatocellular alterations after intraportal transplantation of ovarian tissue in ovariectomized rats. Am J Pathol 156: 1613—1626.

22.

Ledda-Columbano GM , Coni P. , Curto M. , Giacomini L. , Faa G. , Sarma DSR , Columbano A. (1992). Mitogen-induced liver hyperplasia does not substitute for compensatory regeneration during promotion of chemical hepatocarcinogenesis. Carcinogenesis 13: 379—383.

23.

Ledda-Columbano GM , Perra A. , Piga R. , Pibiri M. , Loi R. , Shinozuka H. , Columbano A. (1999). Cell proliferation induced by 3,3',5-triiodo-L-thyronine is associated with a reduction in the number of preneoplastic hepatic lesions. Carcinogenesis 20: 2299—2304.

24.

Ledda-Columbano GM , Perra A. , Loi R. , Shinozuka H. , Columbano A. (2000). Cell proliferation induced by triiodothyronine in rat liver is associated with nodule regression and reduction of hepatocellular carcinomas. Cancer Res 60: 603—609.

25.

Lunn RM , Zhang YJ , Wang LY , Chen CJ , Lee PH , Lee CS , Tsai WY , Santella RM (1997). p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Cancer Res 15: 3471—3477.

26.

Mangelsdorf DJ , Umesono K. , Evans RM (1994). The retinoid receptors . In: The Retinoids, 2nd ed. Sporn MB , Roberts AB , Goodman DS (eds). Raven Press, New York, pp 319—349.

27.

Mayer D. , Metzger C. , Leonetti P. , Beier K. , Benner A. , Bannasch P. (1998). Differential expression of key enzymes of energy metabolism in preneoplastic and neoplastic rat liver lesions induced by N-nitrosomorpholin and dehydroepiandrosterone. Int J Cancer 79: 232—240.

28.

Melnick RD (1992). Does chemically induced hepatocyte proliferation predict liver carcinogenesis? FASEB J 6: 2698—2706.

29.

Michalopoulos GK , DeFrances MC (1997). Liver regeneration . Science 276: 60—66.

30.

Pibiri M. , Ledda-Columbano GM , Cossu C. , Simbula G. , Menegazzi M. , Shinozuka H. , Columbano A. (2001). Cyclin D1 is an early target in hepatocyte proliferation induced by thyroid hormone (T3) FASEB J 15: 1006—1013.

31.

Preston-Martin , Pike MC , Ross RK , Jones PA , Henderson BE (1990). Increased cell division as a cause of human cancer . CancerRes 50: 7415—7421.

32.

Rao MS , Reddy JK (1987). Peroxisome proliferation and hepatocarcinogenesis . Carcinogenesis 8: 631—636.

33.

Short J. , Brown RF , Husakova A. , Gilbertson JR , Zemel R. , Lieberman I. (1972). Induction of deoxyribonucleic acid synthesis in the liver of intact animal. J Biol Chem 247: 1757—1766.

34.

Solt D. , Farber E. (1976). New principle for the analysis of liver carcinogenesis . Am J Pathol 88: 595—618.

35.

Stewart HL , Williams G. , Keysser CH , Lombard LS , Montali R. (1980). Institute of Laboratory Animal Resources: Histological typing of liver tumors of the rat. J Natl Cancer Inst 64: 179—206.

36.

Trichopoulos D. , Lipworth L. , Petridou E. , Adami HO (1997). Epidemiology of cancer. In: Cancer: Principles and Practise of Oncology, De Vita VT , Helmann S , Rosenberg SA (eds). Lippincott-Raven Publishers , Philadelphia, pp 231—257.

37.

Weinstein BI (1991). Mitogenesis is only one factor in carcinogenesis. Science 25: 387—388.